BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 29777767)

  • 1. Biglycan is a new high-affinity ligand for CD14 in macrophages.
    Roedig H; Nastase MV; Frey H; Moreth K; Zeng-Brouwers J; Poluzzi C; Hsieh LT; Brandts C; Fulda S; Wygrecka M; Schaefer L
    Matrix Biol; 2019 Apr; 77():4-22. PubMed ID: 29777767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biglycan evokes autophagy in macrophages via a novel CD44/Toll-like receptor 4 signaling axis in ischemia/reperfusion injury.
    Poluzzi C; Nastase MV; Zeng-Brouwers J; Roedig H; Hsieh LT; Michaelis JB; Buhl EM; Rezende F; Manavski Y; Bleich A; Boor P; Brandes RP; Pfeilschifter J; Stelzer EHK; Münch C; Dikic I; Brandts C; Iozzo RV; Wygrecka M; Schaefer L
    Kidney Int; 2019 Mar; 95(3):540-562. PubMed ID: 30712922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition.
    Erridge C; Kennedy S; Spickett CM; Webb DJ
    J Biol Chem; 2008 Sep; 283(36):24748-59. PubMed ID: 18559343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biglycan- and Sphingosine Kinase-1 Signaling Crosstalk Regulates the Synthesis of Macrophage Chemoattractants.
    Hsieh LT; Nastase MV; Roedig H; Zeng-Brouwers J; Poluzzi C; Schwalm S; Fork C; Tredup C; Brandes RP; Wygrecka M; Huwiler A; Pfeilschifter J; Schaefer L
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28282921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biglycan-triggered TLR-2- and TLR-4-signaling exacerbates the pathophysiology of ischemic acute kidney injury.
    Moreth K; Frey H; Hubo M; Zeng-Brouwers J; Nastase MV; Hsieh LT; Haceni R; Pfeilschifter J; Iozzo RV; Schaefer L
    Matrix Biol; 2014 Apr; 35():143-51. PubMed ID: 24480070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biglycan, a danger signal that activates the NLRP3 inflammasome via toll-like and P2X receptors.
    Babelova A; Moreth K; Tsalastra-Greul W; Zeng-Brouwers J; Eickelberg O; Young MF; Bruckner P; Pfeilschifter J; Schaefer RM; Gröne HJ; Schaefer L
    J Biol Chem; 2009 Sep; 284(36):24035-48. PubMed ID: 19605353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages.
    Schaefer L; Babelova A; Kiss E; Hausser HJ; Baliova M; Krzyzankova M; Marsche G; Young MF; Mihalik D; Götte M; Malle E; Schaefer RM; Gröne HJ
    J Clin Invest; 2005 Aug; 115(8):2223-33. PubMed ID: 16025156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of Toll-like receptors by Burkholderia pseudomallei.
    West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ
    BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate signaling mechanisms controlling Mycobacterium chelonae-mediated CCL2 and CCL5 expression in macrophages.
    Kim YS; Kim JH; Woo M; Kim TS; Sohn KM; Lee YH; Jo EK; Yuk JM
    J Microbiol; 2015 Dec; 53(12):864-74. PubMed ID: 26626357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKR regulates TLR2/TLR4-dependent signaling in murine alveolar macrophages.
    Cabanski M; Steinmüller M; Marsh LM; Surdziel E; Seeger W; Lohmeyer J
    Am J Respir Cell Mol Biol; 2008 Jan; 38(1):26-31. PubMed ID: 17690330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression.
    Perera PY; Mayadas TN; Takeuchi O; Akira S; Zaks-Zilberman M; Goyert SM; Vogel SN
    J Immunol; 2001 Jan; 166(1):574-81. PubMed ID: 11123339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble biglycan induces the production of ICAM-1 and MCP-1 in human aortic valve interstitial cells through TLR2/4 and the ERK1/2 pathway.
    Song R; Ao L; Zhao KS; Zheng D; Venardos N; Fullerton DA; Meng X
    Inflamm Res; 2014 Sep; 63(9):703-10. PubMed ID: 24875140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis.
    Bowdish DM; Sakamoto K; Kim MJ; Kroos M; Mukhopadhyay S; Leifer CA; Tryggvason K; Gordon S; Russell DG
    PLoS Pathog; 2009 Jun; 5(6):e1000474. PubMed ID: 19521507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TLR2-dependent recognition of Streptococcus suis is modulated by the presence of capsular polysaccharide which modifies macrophage responsiveness.
    Graveline R; Segura M; Radzioch D; Gottschalk M
    Int Immunol; 2007 Apr; 19(4):375-89. PubMed ID: 17307800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early p38 Activation Regulated by MKP-1 Is Determinant for High Levels of IL-10 Expression Through TLR2 Activation.
    Francisco S; Arranz A; Merino J; Punzón C; Perona R; Fresno M
    Front Immunol; 2021; 12():660065. PubMed ID: 34234775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Poly-γ-d-Glutamic Acid Capsule Surrogate of the Bacillus anthracis Capsule Is a Novel Toll-Like Receptor 2 Agonist.
    Jeon JH; Lee HR; Cho MH; Park OK; Park J; Rhie GE
    Infect Immun; 2015 Oct; 83(10):3847-56. PubMed ID: 26195551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury.
    Rusai K; Sollinger D; Baumann M; Wagner B; Strobl M; Schmaderer C; Roos M; Kirschning C; Heemann U; Lutz J
    Pediatr Nephrol; 2010 May; 25(5):853-60. PubMed ID: 20130923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockout of Toll-Like Receptors 2 and 4 Prevents Renal Ischemia-Reperfusion-Induced Cardiac Hypertrophy in Mice.
    Trentin-Sonoda M; da Silva RC; Kmit FV; Abrahão MV; Monnerat Cahli G; Brasil GV; Muzi-Filho H; Silva PA; Tovar-Moll FF; Vieyra A; Medei E; Carneiro-Ramos MS
    PLoS One; 2015; 10(10):e0139350. PubMed ID: 26448184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bimodal role of NADPH oxidases in the regulation of biglycan-triggered IL-1β synthesis.
    Hsieh LT; Frey H; Nastase MV; Tredup C; Hoffmann A; Poluzzi C; Zeng-Brouwers J; Manon-Jensen T; Schröder K; Brandes RP; Iozzo RV; Schaefer L
    Matrix Biol; 2016 Jan; 49():61-81. PubMed ID: 26689330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Neoglycoconjugate Containing the Human Milk Sugar LNFPIII Drives Anti-Inflammatory Activation of Antigen Presenting Cells in a CD14 Dependent Pathway.
    Tundup S; Srivastava L; Norberg T; Watford W; Harn D
    PLoS One; 2015; 10(9):e0137495. PubMed ID: 26340260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.